Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 7, 2008; 14(21): 3301-3305
Published online Jun 7, 2008. doi: 10.3748/wjg.14.3301
Published online Jun 7, 2008. doi: 10.3748/wjg.14.3301
Histologic differential diagnosis |
Autoimmune liver disease |
Autoimmune hepatitis |
Primary biliary cirrhosis |
Primary sclerosing cholangitis |
Variant syndromes |
Chronic viral hepatitis |
Chronic hepatitis B |
Chronic hepatitis C |
Chronic hepatitis delta |
Chronic hepatitis due to other viruses |
Chronic drug-induced hepatitis |
Alpha1-antitrypsin deficiency |
Wilson’s disease |
Granulomatous hepatitis |
Systemic lupus erythematosus |
Graft-versus-host disease |
Alcoholic steatohepatitis |
Nonalcoholic steatohepatitis |
Disorder | Characteristic autoantibodies |
Type 1 | ANA (antinuclear antibody) |
SMA (smooth muscle antibody) | |
AAA (anti-actin antibody) | |
Anti SLA/LP (anti-soluble liver antigen/liver-pancreas antigen) | |
pANCA (atypical perinuclear antineutrophil cytoplasmic antibody) | |
AMA (antimitochondrial antibody)1 | |
Type 2 | ALKM-1 (anti-liver/kidney microsome-1) |
ALC-1 (anti-liver cytosol-1) |
Regimen | Single-drug therapy | Combination therapy |
Initial | Prednisone 20-60 mg/d | Prednisone 15-30 mg/d and azathioprine 50-100 mg/d |
Maintenance | Prednisone 5-15 mg/d or azathioprine 50-200 mg/d | Prednisone 5-10 mg/d and azathioprine 50-150 mg/d |
- Citation: Krawitt EL. Clinical features and management of autoimmune hepatitis. World J Gastroenterol 2008; 14(21): 3301-3305
- URL: https://www.wjgnet.com/1007-9327/full/v14/i21/3301.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3301